Genzyme Belgium Genzyme Corporate Search Contact us
HealthcarePatients & FamiliesPractical Info
A disease with many faces
 
Healthcare Professionals
About Lysosomal Storage Disease
Gaucher
Disease Information
Management of Gaucher disease
Therapeutic management
About CerezymeŽ
The effectiveness of CerezymeŽ
Summary of Product Characteristics
Medical Information Services
Gaucher Registry
Practical Information
Request Materials
Fabry
MPS I
Pompe

 



  

Gaucher Disease

Summary of Product Characteristics

Gaucher – CerezymeŽ

Click here for Dutch version (PDF)
Click here for French version (PDF)
 
Print

PRINT

 		Bookmark

BOOKMARK



01/01/2007: Low bone density in Gaucher disease improves with CerezymeŽ

01/05/2007: Treatment for Pompe disease now available for Belgian patients

01/03/2006: Early treatment with FabrazymeŽ significantly slows progression of Fabry

More >


Lysosomal Storage Disorders
General information
Gaucher Disease
Fabry Disease
MPS I Disease
Pompe Disease


 

Terms and Conditions of Use | Privacy Policy | © 2012 Genzyme Corporation, a Sanofi Company. All rights reserved.